Literature DB >> 18595015

Early gastric cancer shows different associations with adipose tissue volume depending on histological type.

Kensuke Otani1, Joji Kitayama, Shoichi Kaisaki, Hironori Ishigami, Akio Hidemura, Mitsuhiro Fujishiro, Masao Omata, Hirokazu Nagawa.   

Abstract

BACKGROUND: Visceral obesity is known to be a risk factor for diabetes and cardiovascular disease. Cancer of the gastric cardia has been shown to have a close association with obesity in Western countries. In order to examine the possible relationship between fat volume and the development of gastric cancer (GC), we quantified visceral and subcutaneous fat areas of computed tomography (CT) images of patients with early GC.
METHODS: A total of 210 patients who underwent endoscopic resection or surgical gastrectomy and whose disease was pathologically diagnosed as early GC were investigated for total fat area (TFA), visceral fat area (VFA), and subcutaneous fat area (SFA) with Fat Scan software, using a CT slice at the umbilical level, and the relationships of these findings with clinical and pathological data were analyzed. The same analysis was performed in 147 patients with early colorectal cancer (CRC).
RESULTS: TFA, VFA, and SFA values in GC patients were not significantly different from the values in CRC patients. These values did not differ with the location of the GC. However, patients with undifferentiated-type GC had significantly smaller VFAs and SFAs than those with differentiated-type GC. Among the patients with undifferentiated GC, TFA and SFA values in the patients with submucosal cancer were significantly smaller than those in the patients with mucosal cancer.
CONCLUSION: GC has different associations with adipose tissue volume according to its histological type. As compared with differentiated GC, lower adipose tissue volume may be a preferential environment for the development and progression of undifferentiated GC.

Entities:  

Mesh:

Year:  2008        PMID: 18595015     DOI: 10.1007/s10120-008-0459-6

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  75 in total

1.  The association of cardiovascular disease risk factors with abdominal obesity in Canada. Canadian Heart Health Surveys Research Group.

Authors:  B A Reeder; A Senthilselvan; J P Després; A Angel; L Liu; H Wang; S W Rabkin
Journal:  CMAJ       Date:  1997-07-01       Impact factor: 8.262

Review 2.  Nutrition and prostate cancer.

Authors:  L N Kolonel
Journal:  Cancer Causes Control       Date:  1996-01       Impact factor: 2.506

3.  Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation.

Authors:  D Forman; D G Newell; F Fullerton; J W Yarnell; A R Stacey; N Wald; F Sitas
Journal:  BMJ       Date:  1991-06-01

Review 4.  Mechanisms of disease: adipokines and breast cancer - endocrine and paracrine mechanisms that connect adiposity and breast cancer.

Authors:  Andreas Schäffler; Jürgen Schölmerich; Christa Buechler
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2007-04

5.  Adiponectin induces growth arrest and apoptosis of MDA-MB-231 breast cancer cell.

Authors:  Jee Hyun Kang; Yoon Young Lee; Byung Yeon Yu; Beom-Seok Yang; Kyung-Hwan Cho; Do Kyoung Yoon; Yong Kyun Roh
Journal:  Arch Pharm Res       Date:  2005-11       Impact factor: 4.946

6.  Association between body mass and adenocarcinoma of the esophagus and gastric cardia.

Authors:  J Lagergren; R Bergström; O Nyrén
Journal:  Ann Intern Med       Date:  1999-06-01       Impact factor: 25.391

Review 7.  Nutrition and colorectal cancer.

Authors:  J D Potter
Journal:  Cancer Causes Control       Date:  1996-01       Impact factor: 2.506

8.  A population-based case-control study of thyroid cancer.

Authors:  E Ron; R A Kleinerman; J D Boice; V A LiVolsi; J T Flannery; J F Fraumeni
Journal:  J Natl Cancer Inst       Date:  1987-07       Impact factor: 13.506

Review 9.  Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer.

Authors:  Gen Tamura
Journal:  World J Gastroenterol       Date:  2006-01-14       Impact factor: 5.742

10.  Visceral obesity in Japanese patients with metabolic syndrome: reappraisal of diagnostic criteria by CT scan.

Authors:  Mariko Eguchi; Kazufumi Tsuchihashi; Shigeyuki Saitoh; Yoshihiro Odawara; Tohru Hirano; Tomoaki Nakata; Tetsuji Miura; Nobuyuki Ura; Masato Hareyama; Kazuaki Shimamoto
Journal:  Hypertens Res       Date:  2007-04       Impact factor: 3.872

View more
  4 in total

1.  Decreased body fat and gastric cancer: does the hen come before the egg, or vice versa?

Authors:  Peter Gunvén
Journal:  Gastric Cancer       Date:  2008       Impact factor: 7.370

2.  Prognostic Value of Pretreatment Overweight/Obesity and Adipose Tissue Distribution in Resectable Gastric Cancer: A Retrospective Cohort Study.

Authors:  Lihu Gu; Yangfan Zhang; Jiaze Hong; Binbin Xu; Liuqiong Yang; Kun Yan; Jingfeng Zhang; Ping Chen; Jianjun Zheng; Jie Lin
Journal:  Front Oncol       Date:  2021-06-24       Impact factor: 6.244

3.  Patients with old age or proximal tumors benefit from metabolic syndrome in early stage gastric cancer.

Authors:  Xiao-li Wei; Miao-zhen Qiu; Huan-xin Lin; Ying Zhang; Jian-xin Liu; Hong-mei Yu; Wei-ping Liang; Ying Jin; Chao Ren; Ming-ming He; Wei-wei Chen; Hui-yan Luo; Zhi-qiang Wang; Dong-sheng Zhang; Feng-hua Wang; Yu-hong Li; Rui-hua Xu
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

4.  Metformin limits the adipocyte tumor-promoting effect on ovarian cancer.

Authors:  Calvin Tebbe; Jasdeep Chhina; Sajad A Dar; Kalli Sarigiannis; Shailendra Giri; Adnan R Munkarah; Ramandeep Rattan
Journal:  Oncotarget       Date:  2014-07-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.